Columbia University
New York, 10023, United States
NCT Number: NCT00136838
Recent research on the effects of nicotine on the brain and behavior presents an opportunity to advance medication development.
The purpose of this study is to develop a laboratory model for early-stage testing of new and existing treatments for nicotine addiction. Specifically, the investigators will develop a laboratory model of relapse to cigarette use in nicotine dependent volunteers.
Looking for future studies?
Notify Me21 year–45 year
All sexes
Interventional
Not applicable
New York, 10023, United States
Tobacco use is the leading preventable cause of death in the United States. Recent research on the effects of nicotine on the brain and behavior presents an opportunity to advance medication development. The goal of this study is to develop a laboratory model for early-stage testing of new and existing compounds for the treatment of tobacco and nicotine addiction. In addition, the objective of this study is to develop a laboratory model of relapse induced by cigarette exposure that would reproduce the psychological and physiological processes that are involved when abstinent individuals progress from initial cigarette smoking (lapse) to a pre-abstinence level of use (relapse). Such a model may be used to study the mechanisms of relapse and to screen medications that might be effective in preventing relapse in treatment seekers.
This study will consist of two phases. Each phase will consist of a 5-day inpatient stay. During the first portion of inpatient stay, participants will not be permitted to smoke. During the second portion of inpatient stay, smoking reinstatement will be modeled, as participant will have opportunity to smoke, following the exposure to tobacco-related or control cues. A variety of behavioral, subjective, physiological, and performance measures will be assessed throughout the study.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Packets of cigarettes or cigarette smoke.
Time frame: During Day 4 experimental session
Following 3 days of abstinence participants had an option to smoke cigarettes every 30 minutes for the maximum of 6 choices
Time frame: immediately following cue expose
Measure of self-reported craving on a scale of 0-70 (0=no craving; 70= worst possible craving).
New York State Psychiatric Institute
Other
Effect of Smoking Exposure on Tobacco Self-Administration Following Brief Abstinence
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05447156
Behavior, Chemically-Induced Disorders
Minneapolis, Minnesota, United States
View Trial DetailsNCT03259360
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial DetailsNCT03873337
Behavior, Chemically-Induced Disorders
New Brunswick, New Jersey, United States
View Trial DetailsNCT03553992
Behavior, Chemically-Induced Disorders
San Francisco, California, United States
View Trial Details